Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
The European Respiratory Journal|November 30, 2018
Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registryClemens Heiser, Armin Steffen, Maurits Boon, et al.Chest|October 31, 2021
Diagnostic Performance of Machine Learning-Derived OSA Prediction Tools in Large Clinical and Community-Based SamplesSteven J Holfinger, M Melanie Lyons, Brendan T Keenan, et al.The Journal of Biological Chemistry|May 3, 2012
Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarraysVered Padler-Karavani, Xuezheng Song, Hai Yu, et al.NPJ Precision Oncology|June 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trialIstvan Petak, Maud Kamal, Anna Dirner, et al.Journal of the American Heart Association|December 21, 2018
A Nurse-Led Limited Risk Factor Modification Program to Address Obesity and Obstructive Sleep Apnea in Atrial Fibrillation PatientsAmaryah Yaeger, Nancy R Cash, Tara Parham, et al.Chest|April 19, 2020
Defining Extreme Phenotypes of OSA Across International Sleep CentersFabiola G Rizzatti, Diego R Mazzotti, Jesse Mindel, et al.Journal of Cardiovascular Electrophysiology|January 10, 2020
Impact of a nurse-led limited risk factor modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablationAmaryah Yaeger, Brendan T Keenan, Nancy R Cash, et al.JAMA Oncology|February 14, 2020
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 TrialRita Nanda, Minetta C Liu, Christina Yau, et al.The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast CancerHope S Rugo, Olufunmilayo I Olopade, Angela DeMichele, et al.The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Neratinib in Early Breast CancerJohn W Park, Minetta C Liu, Douglas Yee, et al.Pageof 7